3D ultrasound scan to guide treatment decisions in liver cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver metastases from colorectal low-grade adenocarcinoma, confirmed by biopsy or typical scan findings, and you are starting a new cancer treatment.
- You are 18 years or older.
- You have at least one liver spot to measure at least 1 cm but no bigger than 14 cm that can be seen with ultrasound.
- You can follow study instructions and are willing to have the ultrasound exams.
- You can consent in writing (or have a legal representative if you cannot consent yourself).
- You are not pregnant and not breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
This study is testing a new way to use ultrasound to help treat colorectal cancer that has spread to the liver. It may help doctors see how tumors respond to treatment.
This study tests a new ultrasound technique to predict whether chemotherapy will work on colorectal cancer that has spread to your liver. The technique uses sound waves and a special contrast dye to measure blood flow in tumors before treatment starts, which may help doctors know early if the treatment is working.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This trial uses a special, high-detail ultrasound to get clearer images of liver tumors. It may help doctors better understand your tumor without extra procedures.
This study uses a new 3D ultrasound scan while you get standard care for a liver or kidney biopsy or ablation. The goal is to see whether the imaging is clear and useful during these procedures.
Hear when a new Liver Cancer, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.